Howe Jill Ann 4
4 · Lineage Cell Therapeutics, Inc. · Filed Nov 26, 2024
Insider Transaction Report
Form 4
Howe Jill Ann
Chief Financial Officer
Transactions
- Purchase
Common Shares
2024-11-26$0.59/sh+15,000$8,850→ 25,500 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5925 to $0.5929, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.